|Bid||8.06 x 1100|
|Ask||9.60 x 800|
|Day's Range||8.12 - 8.81|
|52 Week Range||4.61 - 27.74|
|Beta (5Y Monthly)||1.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 09, 2023 - Jan 13, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.93|
Subscribe to Yahoo Finance Plus to view Fair Value for ACCD
Braze, Inc. (BRZE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Accolade, Inc. (Nasdaq: ACCD), which provides millions of people and their families with Personalized Healthcare, will address removing barriers to equitable healthcare as a Health Equity Impact Champion sponsor at HLTH 2022. In addition, LGBTQIA+ affirming care company, FOLX Health, joins Accolade's Trusted Partner Ecosystem, availing high-quality, integrated care for this marginalized population to Accolade 's 700+ commercial and government customers to serve their 11 million members.
While it may not be enough for some shareholders, we think it is good to see the Accolade, Inc. ( NASDAQ:ACCD ) share...